Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2012

View Archived Issues

FANG cancer vaccine evaluated in phase I trial

JVRS-100 improves H5N1 vaccine immunogenicity

Novel muscarinic acetylcholine M1 receptor modulators disclosed

U.S. researchers prepare new vaccines

Novel protein kinase inhibitors disclosed by SBI Biotech and CrystalGenomics

NeuroSearch patents novel monoamine neurotransmitter reuptake inhibitors

Roche presents novel AMPK activators

University of Illinois forms new start-up company for cancer products

Medicure to commence SAVI-PCI trial of Aggrastat

Immune Pharmaceuticals granted funds by Israel's Office of the Chief Scientist

Study identifies potential biomarkers of Huntington's disease progression

Transcend-trastuzumab conjugate BT-2111 program advances

AMAG Pharmaceuticals completes enrollment in Feraheme trial

New antibodies designed by Novo Nordisk for hemophilia

Allos Therapeutics requests reexamination of CHMP opinion on Folotyn

FDA approves first treatment for advanced BCC

Health Canada accepts CIP-Isotretinoin submission for review

Jentadueto approved in U.S.

Servier and Monash University establish GPCR collaboration

Domain Therapeutics receives award to develop therapeutics for Parkinson's disease

Orexo ends collaboration with Janssen

Takeda returns Posidur rights to Durect

ATS-907 enters clinical development

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...